TickerFiles

Bionano Genomics, Inc. 10-Q filing

Filed 2025-08-14 · Report date 2025-06-30 · 2025

View Original SEC Filing

Filing metadata

Accession number
0001411690-25-000083
Form type
10-Q
CIK
0001411690
Primary document
https://www.sec.gov/Archives/edgar/data/1411690/000141169025000083/bngo-20250630.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Bionano Genomics, Inc..

Reported financial metrics

MetricCurrentPriorChange
Revenue$13.2M--
Cost Of Revenue$6.8M--
Operating Income$-16.3M--
Net Income$-10.0M--
Eps Basic-3.24--
Eps Diluted-3.24--
Cash And Equivalents$3.6M--
Total Assets$76.0M--
Total Liabilities$30.6M--
Shareholders Equity$45.4M--
Operating Cash Flow$-6.3M--